{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:58:00Z","timestamp":1791363480883,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40291-015-0171-2","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T12:59:40Z","timestamp":1444222780000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile Analysis"],"prefix":"10.1007","volume":"19","author":[{"given":"Pawel","family":"Borun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacper","family":"Salanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Godlewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Walkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Plawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"issue":"12","key":"171_CR1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/35103059","volume":"2","author":"J Bartek","year":"2001","unstructured":"Bartek J, Falck J, Lukas J. CHK2 kinase: a busy messenger. Nat Rev Mol Cell Biol. 2001;2(12):877\u201386. doi: 10.1038\/35103059 .","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5449","key":"171_CR2","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","volume":"286","author":"DW Bell","year":"1999","unstructured":"Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 1999;286(5449):2528\u201331.","journal-title":"Science"},{"issue":"5","key":"171_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003;3(5):421\u20139.","journal-title":"Cancer Cell"},{"issue":"43","key":"171_CR4","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1038\/sj.onc.1209877","volume":"25","author":"H Nevanlinna","year":"2006","unstructured":"Nevanlinna H, Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene. 2006;25(43):5912\u20139. doi: 10.1038\/sj.onc.1209877 .","journal-title":"Oncogene"},{"issue":"15","key":"171_CR5","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddm127","volume":"16","author":"P Brennan","year":"2007","unstructured":"Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, et al. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum Mol Genet. 2007;16(15):1794\u2013801. doi: 10.1093\/hmg\/ddm127 .","journal-title":"Hum Mol Genet"},{"issue":"10","key":"171_CR6","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/sj.bjc.6601425","volume":"89","author":"EH Sepp\u00e4l\u00e4","year":"2003","unstructured":"Sepp\u00e4l\u00e4 EH, Ikonen T, Mononen N, Autio V, R\u00f6kman A, Matikainen MP, et al. CHEK2 variants associate with hereditary prostate cancer. Br J Cancer. 2003;89(10):1966\u201370. doi: 10.1038\/sj.bjc.6601425 .","journal-title":"Br J Cancer"},{"issue":"12","key":"171_CR7","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1158\/1055-9965.EPI-06-0687","volume":"15","author":"D Thompson","year":"2006","unstructured":"Thompson D, Seal S, Schutte M, McGuffog L, Barfoot R, Renwick A, et al. A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiol Biomark Prev. 2006;15(12):2542\u20135. doi: 10.1158\/1055-9965.EPI-06-0687 .","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"171_CR8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","volume":"75","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet. 2004;75(6):1131\u20135.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"171_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jmg.2008.061697","volume":"46","author":"C Cybulski","year":"2009","unstructured":"Cybulski C, G\u00f3rski B, Huzarski T, Byrski T, Gronwald J, Debniak T, et al. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations. J Med Genet. 2009;46(2):132\u20135. doi: 10.1136\/jmg.2008.061697 .","journal-title":"J Med Genet"},{"issue":"3","key":"171_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10549-011-1635-7","volume":"132","author":"P Domagala","year":"2012","unstructured":"Domagala P, Wokolorczyk D, Cybulski C, Huzarski T, Lubinski J, Domagala W. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012;132(3):937\u201345. doi: 10.1007\/s10549-011-1635-7 .","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"171_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10689-012-9599-2","volume":"12","author":"U Teodorczyk","year":"2013","unstructured":"Teodorczyk U, Cybulski C, Woko\u0142orczyk D, Jakubowska A, Starzy\u0144ska T, Lawniczak M, et al. The risk of gastric cancer in carriers of CHEK2 mutations. Fam Cancer. 2013;12(3):473\u20138. doi: 10.1007\/s10689-012-9599-2 .","journal-title":"Fam Cancer"},{"issue":"1","key":"171_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1897-4287-12-10","volume":"12","author":"A B\u0105k","year":"2014","unstructured":"B\u0105k A, Janiszewska H, Junkiert-Czarnecka A, Heise M, Pilarska-Deltow M, Laskowski R, et al. A risk of breast cancer in women: carriers of constitutional CHEK2 gene mutations, originating from the North\u2014Central Poland. Hereditary Cancer Clin Pract. 2014;12(1):10. doi: 10.1186\/1897-4287-12-10 .","journal-title":"Hereditary Cancer Clin Pract"},{"issue":"11","key":"171_CR13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2006.044974","volume":"43","author":"C Cybulski","year":"2006","unstructured":"Cybulski C, Wokolorczyk D, Huzarski T, Byrski T, Gronwald J, Gorski B, et al. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet. 2006;43(11):863\u20136. doi: 10.1136\/jmg.2006.044974 .","journal-title":"J Med Genet"},{"issue":"1","key":"171_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cancergencyto.2009.11.015","volume":"199","author":"U Scharrer","year":"2010","unstructured":"Scharrer U, Skrzypczak-Zielinska M, Wituszynska W, Mierzejewski M, Krause K, Cybulski C, et al. A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia. Cancer Genet Cytogenet. 2010;199(1):48\u201352. doi: 10.1016\/j.cancergencyto.2009.11.015 .","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"171_CR15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.29426","volume":"137","author":"M Siolek","year":"2015","unstructured":"Siolek M, Cybulski C, Gasior-Perczak D, Kowalik A, Kozak-Klonowska B, Kowalska A, et al. CHEK2 mutations and the risk of papillary thyroid cancer. Int J Cancer. 2015;137(3):548\u201352. doi: 10.1002\/ijc.29426 .","journal-title":"Int J Cancer"},{"issue":"1","key":"171_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13053-015-0030-5","volume":"13","author":"M Kaczmarek-Rys","year":"2015","unstructured":"Kaczmarek-Rys M, Ziemnicka K, Hryhorowicz ST, Gorczak K, Hoppe-Golebiewska J, Skrzypczak-Zielinska M, et al. The c.470 T>C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population. Hereditary Cancer Clin Pract. 2015;13(1):8. doi: 10.1186\/s13053-015-0030-5 .","journal-title":"Hereditary Cancer Clin Pract"},{"issue":"3","key":"171_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2006.05.040","volume":"102","author":"J Szymanska-Pasternak","year":"2006","unstructured":"Szymanska-Pasternak J, Szymanska A, Medrek K, Imyanitov EN, Cybulski C, Gorski B, et al. CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors. Gynecol Oncol. 2006;102(3):429\u201331. doi: 10.1016\/j.ygyno.2006.05.040 .","journal-title":"Gynecol Oncol"},{"issue":"1","key":"171_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-006-9320-y","volume":"102","author":"C Cybulski","year":"2007","unstructured":"Cybulski C, Woko\u0142orczyk D, Huzarski T, Byrski T, Gronwald J, G\u00f3rski B, et al. A deletion in CHEK2 of 5395\u00a0bp predisposes to breast cancer in Poland. Breast Cancer Res Treat. 2007;102(1):119\u201322. doi: 10.1007\/s10549-006-9320-y .","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"171_CR19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ejca.2008.09.022","volume":"45","author":"Z Kleibl","year":"2009","unstructured":"Kleibl Z, Havranek O, Hlavata I, Novotny J, Sevcik J, Pohlreich P, et al. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population. Eur J Cancer. 2009;45(4):618\u201324. doi: 10.1016\/j.ejca.2008.09.022 .","journal-title":"Eur J Cancer"},{"issue":"6","key":"171_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/14622416.8.6.597","volume":"8","author":"GH Reed","year":"2007","unstructured":"Reed GH, Kent JO, Wittwer CT. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics. 2007;8(6):597\u2013608. doi: 10.2217\/14622416.8.6.597 .","journal-title":"Pharmacogenomics"},{"issue":"5","key":"171_CR21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00439-013-1393-1","volume":"133","author":"P Borun","year":"2014","unstructured":"Borun P, Kubaszewski L, Banasiewicz T, Walkowiak J, Skrzypczak-Zielinska M, Kaczmarek-Rys M, et al. Comparative-high resolution melting: a novel method of simultaneous screening for small mutations and copy number variations. Hum Genet. 2014;133(5):535\u201345. doi: 10.1007\/s00439-013-1393-1 .","journal-title":"Hum Genet"},{"issue":"8","key":"171_CR22","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-04-0341","volume":"64","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, Huzarski T, Gorski B, Masojc B, Mierzejewski M, Debniak T, et al. A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res. 2004;64(8):2677\u20139.","journal-title":"Cancer Res"},{"issue":"12","key":"171_CR23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. 2006;295(12):1379\u201388. doi: 10.1001\/jama.295.12.1379 .","journal-title":"JAMA"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-015-0171-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0171-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:06:00Z","timestamp":1553627160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-015-0171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1007\/s40291-015-0171-2","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}